Postchallenge Hyperglycemia in a National Sample of U.S. Adults With Type 2 Diabetes
- 1 October 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (10), 1734-1738
- https://doi.org/10.2337/diacare.24.10.1734
Abstract
OBJECTIVE—Postchallenge hyperglycemia (PCH) is known to contribute to suboptimal glycemic control in adults with non–insulin-requiring type 2 diabetes. The objective of this study was to estimate the prevalence of PCH among individuals with diabetes. RESEARCH DESIGN AND METHODS—We conducted a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey (1988–1994) in adults aged 40–74 years with diabetes who were not using insulin (i.e., they used oral hypoglycemics or received no pharmacological therapy). Each respondent underwent a standard 75-g oral glucose tolerance test. PCH was defined as a 2-h glucose level ≥200 mg/dl. RESULTS—Overall, PCH was present in 74% of those with diagnosed diabetes. Although it was present in virtually all (99%) of the diabetic adults under suboptimal glycemic control (HbA1c ≥7.0%), PCH was also common (39%) among those under optimal control (HbA1c <7.0%). Likewise, among sulfonylurea users, PCH was present in 99% of those under suboptimal control and in 63% of those under good control. Similar patterns were observed in those with undiagnosed diabetes. Isolated PCH (2-h glucose ≥200 mg/dl and fasting glucose <126 mg/dl) was present in 9.8% of the adults with diagnosed diabetes. CONCLUSIONS—These data suggest that PCH is common among diabetic adults in the U.S., even in the setting of “optimal” glycemic control and sulfonylurea use. Interventions designed to lower postprandial glucose excursions may help improve overall glycemic control in the general population of U.S. adults with diabetes.Keywords
This publication has 24 references indexed in Scilit:
- Diabetes guidelines: A summary and comparison of the recommendations of the american diabetes association, veterans health administration, and american association of clinical endocrinologistsClinical Therapeutics, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJCI Insight, 1999
- A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)Diabetes Care, 1999
- Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individualsAtherosclerosis, 1999
- The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn StudyDiabetes Care, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin LevelsPublished by American Medical Association (AMA) ,1996
- Effect of Metformin on Postprandial Lipemia in Patients With Fairly to Poorly Controlled NIDDMDiabetes Care, 1994
- Self-Monitoring of Blood Glucose by Adults With Diabetes in the United States PopulationDiabetes Care, 1993
- Comparison of peripheral glucose uptake after oral glucose loading and a mixed mealMetabolism, 1983